Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05187182
Title CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

gastric squamous cell carcinoma

gastric adenocarcinoma

esophagus squamous cell carcinoma

Therapies

CA-4948 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin

CA-4948 + Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab + Trastuzumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.